• Sulfamonomethoxine Biotransformation in Granular Sludge

  2026-08-26

  The reference study shows that aerobic granular sludge removes sulfamonomethoxine mainly through biodegradation rather than adsorption, with tightly bound extracellular polymeric substances influencing sorption behavior. Its strongest mechanistic contribution is evidence that hydroxylamine and hydroxylamine oxidoreductase are important in SMM transformation, including a pathway suggested by the transformation product TP202.

• DiscoveryProbe Natural Product Library Plus for AdhE

  2026-08-26

  Discover how the DiscoveryProbe Natural Product Library Plus can support a staged strategy for enzyme-to-phenotype research, using Cryptosporidium parvum AdhE as a model. This article focuses on assay architecture, mechanistic confidence, and practical screening decisions rather than a conventional library overview.

• Hexose Diphosphate as a Translational Metabolic Probe

  2026-08-25

  Hexose diphosphate offers translational researchers a practical way to connect carbohydrate flux, energy homeostasis, ischemic injury, and inflammatory biology. This thought-leadership guide explains how to position it as a mechanistic research tool while distinguishing established evidence from testable hypotheses inspired by recent PEP–cGAS findings.

• Mubritinib–HSA Binding: Mechanisms and Implications

  2026-08-25

  The 2023 Molecular Pharmaceutics study combined fluorescence spectroscopy, biochemical testing, and molecular docking to define how mubritinib associates with human serum albumin. Its evidence supports a moderately strong, mainly noncovalent interaction at Sudlow site I, with measurable but limited effects on albumin structure and esterase-like function.

• Estradiol Benzoate: Assay Design Beyond Binding

  2026-08-24

  Estradiol Benzoate is a high-affinity estrogen receptor alpha agonist for dissecting receptor activity with greater experimental precision. This guide translates receptor pharmacology and computational screening logic into practical assay decisions, controls, and reproducibility safeguards.

• Estradiol Benzoate: ERα Assay Workflows

  2026-08-24

  Estradiol Benzoate provides a practical, high-affinity agonist format for connecting estrogen receptor alpha binding with transcriptional and cellular signaling readouts. This guide combines stock preparation, dose-response design, orthogonal validation, and troubleshooting for more reproducible hormone receptor experiments.

• Fingolimod (FTY720) in CAR-T-Mimic Assays

  2026-08-23

  Fingolimod (FTY720) offers a controllable way to interrogate S1P-regulated lymphocyte trafficking alongside magnetically guided CAR-T-mimicking cell systems. This article translates the reference study into practical assay designs, formulation guidance, and troubleshooting steps without overstating an unvalidated combination.

• Temozolomide as a Translational Stress Test in Glioma

  2026-08-22

  Temozolomide is more than a cytotoxic control: it is a mechanistically defined DNA damage challenge for linking ATRX status, DNA repair biology, and combination-response strategies in glioma models. This thought-leadership guide translates the evidence into practical experimental and translational guidance.

• Guinea Pig–Mouse Penile Development and SHH

  2026-08-22

  Wang and Zheng used comparative embryology, gene-expression profiling, and genital-tubercle explant assays to explain why guinea pigs form an open urethral groove whereas mice primarily canalize a tubular urethra. Their findings implicate differential Shh and Fgf10/Fgfr2 activity in coordinating preputial development and urethral morphogenesis, providing a useful framework for comparative congenital malformation research.

• CpAdhE Inhibition by Antifungal Imidazoles

  2026-08-21

  Chen et al. characterized the bacterial-type bifunctional aldehyde/alcohol dehydrogenase CpAdhE as a metabolic vulnerability in Cryptosporidium parvum and linked enzyme inhibition with parasite-growth suppression. Their target-to-phenotype workflow identified several low-micromolar antifungal imidazoles, providing a rational starting point for anti-cryptosporidial drug discovery while leaving target selectivity and in vivo efficacy unresolved.

• iRGD-RBC Membrane Delivery Boosts Neuroblastoma PDT

  2026-08-20

  Wu and colleagues developed iRGD-functionalized red blood cell membrane vesicles to deliver the photosensitizer TPOR for neuroblastoma photodynamic therapy. The biomimetic carrier combined prolonged-circulation features with tumor-penetrating functionality, improving drug release, cellular uptake, apoptosis induction, migration inhibition, and tumor control compared with free TPOR.

• IGFBP2–THBS1 Axis in GH-Mediated Bone Growth

  2026-08-20

  The reference study identifies an IGFBP2–THBS1 regulatory axis that links growth hormone treatment to IGF-1 signaling, chondrocyte proliferation, and hypertrophic differentiation in idiopathic short stature. Its combination of patient-derived proteomic analysis, human chondrocyte experiments, and IGFBP2 loss- and gain-of-function approaches provides a mechanistic framework for understanding variable responses to GH therapy.

• PreScission Protease for Tag Cleavage

  2026-08-19

  PreScission Protease combines sequence-selective fusion protein tag cleavage with low-temperature handling, supporting recovery of native proteins for binding, structural, and chromatin-related assays. This article translates findings on Drosophila Keap1 and lamin Dm0 into practical purification and assay-design choices while distinguishing established evidence from workflow recommendations.

• Structure-Based Screening of SARS-CoV-2 NSP15 Inhibitors

  2026-08-19

  The reference study used virtual screening and molecular dynamics simulations to evaluate natural products against the SARS-CoV-2 NSP15 endoribonuclease. Thymopentin and oleuropein produced the most favorable computational profiles, providing testable starting points for biochemical validation rather than clinically established antiviral treatments.

• Dasatinib Monohydrate: BMS-354825 Research Guide

  2026-08-18

  Dasatinib Monohydrate, also called BMS-354825, is an ATP-competitive multitargeted tyrosine kinase inhibitor for BCR-ABL, SRC, KIT, and PDGFR research. Its nanomolar biochemical activity and activity against imatinib-resistant BCR-ABL variants support chronic myeloid leukemia research, while NET-related findings define important translational limits.

8465 records 1/565 page Next 12345 下5页 Last page